Respiratory Monitoring in Pediatric Neuromuscular Disease

Main Article Content

Andre Sugiyono
Siti Chandra Widjanantie

Abstract

ABSTRACTNeuromuscular disease in childhood result in dysfunction of chest wall and lung movement that interfereventilation function and gas exchange. Without vital respiratory pump, ventilation, gas exchangefunction and cough ability would be compromised and could result in complications such as pneumonia,atelectasis, and respiratory failure.Comorbid factors in cardiovascular, musculoskeletal, nutrition, and gastrointestinal could aggravaterespiratory morbidity and mortality if not adequately treated. This paper was written to reviewanatomy and physiology of neurorespiratory system, pathophysiology of respiratory complication inneuromuscular disease, clinical assessment and respiratory monitoring of childhood neuromusculardisease from Physical Medicine and Rehabilitation point of view .Keywords: assessment, neuromuscular disease, pediatric, respiratory, ventilation

Article Details

How to Cite
Andre Sugiyono, & Siti Chandra Widjanantie. (2021). Respiratory Monitoring in Pediatric Neuromuscular Disease. Indonesian Journal of Physical Medicine and Rehabilitation, 10(02), 109 - 118. https://doi.org/10.36803/ijpmr.v10i02.309
Section
Literature Review
Author Biographies

Andre Sugiyono, Medical Staff

Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Indonesia,Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Siti Chandra Widjanantie, Medical Staff

Department of Physical Medicine and Rehabilitation, Universitas Indonesia, Persahabatan GeneralHospital, Jakarta, Indonesia

References

1. Askanas V, King Engel W. Update on neuromuscular diseases: Pathology and
molecular pathogenesis. Biochim Biophys Acta - Mol Basis Dis 2015; 1852(4): 561–2.
2. Pfeffer G, Povitz M. Respiratory management of patients with neuromuscular disease:
current perspectives. Degener Neurol Neuromuscul Dis 2016; 6: 111–8.
3. Tortora G, Derrickson B. The Respiratory System. In: Principles of Anatomy &
Physiology. 15th ed. United States: Wiley; 2017.
4. Malik V, Smith D, Lee-Chiong T. Respiratory physiology during sleep. Sleep Med Clin 2012; 7(3): 497–505.
5. Voulgaris A, Antoniadou M, Agrafiotis M, Steiropoulos P. Respiratory involvement in patients with neuromuscular diseases: A narrative review. Pulm Med 2019; 2019.
6. Farrero E, AntónA, Egea CJ. Guidelines for the management of respiratory complications in patients
with neuromuscular disease. Arch Bronconeumol 2013; 49(7): 306–13.
7. Chiang J, Mehta K, Amin R. Respiratory diagnostic tools in neuromuscular disease children. Children 2018; 5(6): 78.
8. Bach J, Dikeman K, Gaydos J, Guylas A, Haber I. Management of Patients With Neuromuscular Disease. 1st ed. Hanley & Belfus. United States: Hanley & Belfus; 2004.
9. Arnold D, Kassar D, Kissel J. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve 2015; 51(2): 157–67.
10. Engel-hoek L Van Den, Groot IJM De, Swart BJM De, Erasmus CE. Feeding and swallowing disorders in pediatric neuromuscular diseases. J Neuromuscul Dis 2015; 2: 357–69.
11. Hull J, Aniapravan R, Chan E. British thoracic society guideline for respiratory
management of children with neuromuscular weakness. Thorax 2012; 67.
12. Birnkrant DJ, Bushby K, Bann CM, Alman BA. Diagnosis and management of duchenne muscular dystrophy, part 2. Lancet Neurol 2018; 17(4): 347–61.
13. Mercuri E, Finkel RS, Muntoni F. Diagnosis and management of spinal muscular atrophy: Part 1. Neuromuscul Disord 2018; 28(2): 103–15.
14. Grippi M, Elias J, Fishman J, Kotloff R, Pack A, Senior R. Fishman Pulmonary
Disease and Disorders. 5th ed. United States: McGraw-Hill; 2015.
15. Ragette R, Mellies U, Schwake C, Voit T, Teschler H. Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 2002; 57(8): 724–8.
16. Dohna-Schwake C, Ragette R, Teschler H, Voit T, Mellies U. Predictors of severe chest infections in pediatric neuromuscular disorders. Neuromuscul Disord 2006; 16(5): 325–8.
17. Phillips MF, Quinlivan RCM, Edwards RHT, Calverley PMA. Changes in spirometry over time as a prognostic marker in patients with duchenne muscular dystrophy. Am J Respir Crit Care Med 2002; 164(12): 2191–4.
18. Hammer J, Eber E. Paediatric Pulmonary Function Testing. 1st ed. Karger Publishing; 2005. 299 p.
19. Agustriani V, Wahyuni L, Paulus A, Herqutanto. Maximum inspiratory pressure
dan maximum expiratory pressure pada anak Indonesia sehat usia 8-12 tahun di Jakarta; 2019.
20. Nève V, Cuisset JM, Edmé JL. Sniff nasal inspiratory pressure in the longitudinal assessment of young DMD children. Eur Respir J 2013; 42(3): 671–80.
21. Dunaway Young S, Montes J, Kramer SS. Six-minute walk test is reliable and valid
in spinal muscular atrophy. Muscle Nerve 2016; 54(5): 836–42.
22. McDonald C, Henricson E, Han J. The 6-minute walk test as a new outcome measure in duchenne muscular dystrophy. Muscle Nerve 2010; 41: 500–10.